18th Texas Update in Cardiovascular Advancements | Denton A. Cooley Auditorium
All presentations are followed by Q&A with the speaker
7:30 am Continental Breakfast and Exhibits
8:00 Welcome and Introductions | James T. Willerson, MD
8:15 PCKS9 Inhibitors: Are They Alternatives to Treating Elevated LDLs in Patients Intolerant of Statins? | Vijay Nambi, MD, PhD
8:45 Non-Invasive Imaging of Vascular Inflammation | Darren Woodside, PhD
9:15 Latest Development in Treating Patients with TAVR | David Fish, MD
9:45 Hormonal Therapy for Post Menopaused Women at High Risk of CAD: What is Best? | Stephanie Coulter, MD
10:15 Closure Devices for Mitral Valve Regurgitation, ASDs, and VSDs:What Progress Has Been Made? | Guilherme Silva, MD
11:00 Advances in Radiofrequency Ablation of Atrial Fibrillation |Abdi Rasekh, MD
11:30 Questions of the Speakers
Presentation of Ray C. Fish Award and Luncheon | Texas Heart Institute The Ansary Atrium
Noon Introduction of the Ray C. Fish Award and Recipient | James T. Willerson, MD
12:05 Presentation of the Ray C. Fish Award | James T. Willerson, MD
12:15 Luncheon in honor of Ray C. Fish Award Recipient | Emerson Perin, MD, PhD
18th Texas Update in Cardiovascular Advancements | Denton A. Cooley Auditorium
1:15 Ray C. Fish Lecture: Cell Therapy for the Heart: A Journey to Approval Emerson Perin, MD, PhD, Medical Director, Texas Heart Institute (Houston, Texas)
2:00 Treating Patients with CHF and LV Systolic Dysfunction by Treating Mitral Regurgitation | Andrew B. Civitello, MD
2:30 Update on Treatment of DVT | Zvonimir Krajcer, MD
3:00 Treating CHF by Stimulating Cardiogenesis Directly | James F. Martin, MD, PhD
3:30 Questions of the Speakers
3:45 Final Comments and Adjourn | James T. Willerson, MD
Downloadable Agenda